Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -261,281 | -206,470 | -136,061 | -111,399 | -21,226 |
| Depreciation Amortization | 31,464 | 20,225 | 9,880 | 32,792 | 29,042 |
| Accounts receivable | -4,017 | -3,286 | -1,547 | -11,264 | -3,295 |
| Accounts payable and accrued liabilities | -18,573 | -15,641 | -24,841 | 24,763 | 7,468 |
| Other Working Capital | -70,421 | -63,683 | -2,946 | -25,475 | -32,576 |
| Other Operating Activity | 121,073 | 109,607 | 36,510 | -189,438 | -188,961 |
| Operating Cash Flow | $-201,755 | $-159,248 | $-119,005 | $-280,021 | $-209,548 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 271,285 | 216,967 | 111,364 | -109,367 | -96,719 |
| PPE Investments | -82 | -82 | N/A | N/A | -643 |
| Purchase Sale Intangibles | -26,569 | -18,377 | -6,466 | -41,591 | -36,086 |
| Other Investing Activity | -91,569 | -83,377 | -6,466 | 165,143 | 170,088 |
| Investing Cash Flow | $179,634 | $133,508 | $104,898 | $55,776 | $72,726 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 571 | 0 | 0 | 219,068 | 219,068 |
| Other Financing Activity | -268 | 257 | -525 | -316 | -440 |
| Financing Cash Flow | $303 | $257 | $-525 | $218,752 | $218,628 |
| Exchange Rate Effect | 51 | -402 | -293 | 1,981 | 750 |
| Beginning Cash Position | 58,176 | 58,176 | 58,176 | 61,688 | 61,688 |
| End Cash Position | 36,409 | 32,291 | 43,251 | 58,176 | 144,244 |
| Net Cash Flow | $-21,767 | $-25,885 | $-14,925 | $-3,512 | $82,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -201,755 | -159,248 | -119,005 | -280,021 | -209,548 |
| Capital Expenditure | -82 | -82 | N/A | N/A | -643 |
| Free Cash Flow | -201,837 | -159,330 | -119,005 | -280,021 | -210,191 |